Search
Close this search box.
Search
Close this search box.

We deliver on time, as promised and at top quality

CONTRACT MANUFACTURING ORGANIZATION

MabPlex offers end-to-end CMO services including Cell Banking, Protein Related Drug DS/DP Manufacturing, ADC DS/DP Manufacturing, and Product Testing.
Previous slide
Next slide

CELL BANKING

Previous slide
Next slide

MabPlex provides MCB, WCB, and EOPCB banking service in compliance with US FDA, European EMA, and Chinese NMPA GMP regulatory requirements

  • Dual-site cell bank storage
  • Dedicated cell banking suite
  • Real-time cell bank monitoring system and safety management measures
Previous slide
Next slide

MabPlex offers manufacturing services including cell culture by using disposable bioreactors, purification, formulation, fill/finish (both liquid and lyophilized) and package of drug product. State-of-the-art equipment ensures product to be consistently produced with high quality.

  • cGMP Production facilities are fully in compliance with GMP regulations
  • Multiple production scales at 50L, 200L, 500L, 1000L and 2000L implementation of disposable equipment to reduce cross-contamination risks and shorten production cycles
  • Quality management system ensures GMP compliance.

ADC DS/DP MANUFACTURING

Previous slide
Next slide

MabPlex is the one of the leading companies for ADC drug development in the world that provides technically challenging service from development to commercial production including both payload and ADC. MabPlex is equipped with state-of-the-art fill/finish equipment with aseptic filling and lyophilization with automated operation to ensure manufacturing with efficient control. Innovative linker/payload technologies are implemented to ensure product with good therapeutical window and safety. Robust ADC manufacturing process produces ADC with consistent drug to antibody ratios (DAR).

  • Large scale linker/payload synthesis under GMP conditions
  • Broad range of conjugation scales from 10L to 150L
  • GMP fill/finish of ADC products

PRODUCT TESTING

Previous slide
Next slide

Product testing/release, specification setting are based on FDA, EMA, NMPA filing principles and ICH guidelines and life cycle management.

  • In Process Testing and Control: Titer, Protein Concentration, Osmolality, Bacterial Endotoxin, Sterility and so on.
  • Release Testing: for DS/DP release testing, comprehensive assay will be performed, such as identity, purity/impurity, potency, protein strength and safety test, general test, etc.
  • Stability Study: Long Term Stability, Accelerated Stability, Forced Degradation Stability Test and In-use Stability, etc.